Evaluation of the rationality of clinical application of Butylphthalide and Sodium Chloride Injection based on attribute hierarchical model
Objective To establish the evaluation standard for the rational use of Butylphthalide and Sodium Chloride Injection,and provide a basis for rational clinical use of Butylphthalide and Sodium Chloride Injection.Methods The evaluation criteria of Butylphthalide and Sodium Chloride Injection were developed based on the instruction manual and relevant guidelines,and the attribute hierarchical model was used to evaluate 180 discharged medical records of Bozhou People's Hospital from January to July 2023 for Butylphthalide and Sodium Chloride Injection.Results None of the 180 medical records were labeled with titration time in the medical prescription,inappropriate course of treatment in 31 cases(17.22%),over-indication in 22 cases(12.22%),inappropriate frequency of medication in 5 cases(2.78%),over-contraindications in 2 cases(1.1%),and failure to monitor hepatic and renal functions in 5 cases(2.78%).Grade excellent medical records 120 cases(66.67%),good medical records 32 cases(17.78%)and qualified medical records 28 cases(15.55%).Conclusion There are many unreasonable problems with Butylphthalide and Sodium Chloride Injection in Bozhou People's Hospital,which require multi-departmental collaborative intervention for remediation.The drug rationality evaluation based on attribute hierarchical model is simple to operate and has better evaluation results for multi-factor indicators,and this method can be widely used for other drug rationality evaluation.
Butylphthalide and Sodium Chloride Injectionrationality evaluationattribute hierarchical modelhyperindicationfrequency of medicationinfusion time
NETL
NSTL
万方数据
